Category: funding
-
New project funded by Hanarth Foundation!
Cancer-related fatigue affects many people with cancer, yet we still cannot explain why some patients develop severe fatigue or why treatments help some but not others. Our freshly funded project FAIR-CARE takes a fresh approach by studying how symptoms connect and interact, using advanced AI and Bayesian network methods. This project brings together an inspiring…
-
PhD position available!
Understanding how brain cells interact to form circuits, how circuits give rise to networks, and how networks support cognition is one of the most exciting challenges in clinical neuroscience. For complex conditions such as multiple sclerosis and autism spectrum disorder, progress has been slowed by animal models that optimize for single causes or treatments, without…
-
TRANSCEND gets funded by Horizon Europe!
When we first started talking about the translational gap in neuroscience back in 2018, none of us imagined where that conversation would lead. What began as an exchange of ideas between Lara Keuck, Klaus Eyer, and Linda Douw slowly grew into something much larger: a vision to bridge the worlds of basic and clinical neuroscience,…
-
Dorien receives new grant
In the pursuit of improvements in early cancer detection, better diagnostic methods, and more effective treatments, the Cancer Center Amsterdam Foundation annually grants funding to jump-start promising early-stage research projects at Cancer Center Amsterdam. And Dorien received one of them! Her project is entitled “Mapping the functional anatomy of the tumor-brain interface to discover novel treatment…
-
We are ON against cancer!
Dorien, Marike and Linda were in Hilversum to attend a live show organised by the Dutch Cancer Society (KWF kankerbestrijding), themed “Everyone ON against cancer”! As brain tumor researchers, we are working against cancer every day, with the entire MULTINET team and many other colleagues from Amsterdam UMC and beyond. It is great that KWF…
-
Dorien receives Young Investigator Grant from KWF!
Cognitive disorders are a side effect of chemotherapy that can persist long after the treatment is completed and include problems with working memory and concentration. There is no successful treatment strategy for chemotherapy-related cognitive disorders (CRCI) because clinical and preclinical studies are far apart, creating translational problems in the development of treatments. In the brains…
-
Dutch Cancer Society funds our research
We are very happy that the Dutch Cancer Society (KWF) is funding our study GOALS2, which aims to explore the clinical relevance of brain activity as a marker of glioma growth. A very brief explanation (in Dutch) is given by Linda in this video.
-
Two projects funded
Two of our collaborative ideas have received funding from Amsterdam Neuroscience! The first is on linking postmortem MS pathology to large-scale brain network failure (PI: Menno Schoonheim, in the Neuroinflammation theme), the second on multiscale correlates of cognition (PI: Natalia Goriounova in the Systems and Network Neuroscience theme). Much bridging of scales planned for the coming years!
-
BrainLayer: the multilayer brain networks underlying cognitive decline
We are very happy to continue our research with an NWO-Vidi! This is a short summary of the 5-year project: Cognitive deterioration in lesional brain disease, such as cerebrovascular accidents, multiple sclerosis and glioma, weighs heavily on patients, their caregivers and society, particularly since curative treatment is unavailable. Variation in cognitive decline is large: some…
Multiscale Network Neuroscience 